Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUSE
2018-004261-14Phase 4Completed
- Sponsor
- Vestre Viken Hospital Trust
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atorvastatin in coronary arteriosclerosis (2 arms), sponsored by Vestre Viken Hospital Trust. Started Nov 2018; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2018-004261-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004261-14.